Yamazen Corporation (TYO:8051)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	116,592	112,574	119,588	90,354	83,868	98,331
Market Cap Growth	-5.87%	-5.87%	32.36%	7.73%	-14.71%	15.59%
Enterprise Value	56,737	50,846	50,405	26,340	20,813	37,051
Last Close Price	1364.00	1317.00	1296.11	942.40	838.83	894.74
PE Ratio	16.49	14.35	18.43	7.21	6.98	12.99
Forward PE	-	13.76	13.76	13.76	13.76	13.76
PS Ratio	0.23	0.22	0.24	0.17	0.17	0.23
PB Ratio	0.91	0.88	0.90	0.73	0.74	0.91
P/TBV Ratio	1.01	0.97	0.98	0.81	0.83	1.00
P/FCF Ratio	37.32	36.03	13.67	20.47	29.16	10.97
P/OCF Ratio	13.94	13.46	10.72	11.64	11.89	7.25
EV/Sales Ratio	0.11	0.10	0.10	0.05	0.04	0.09
EV/EBITDA Ratio	3.96	3.55	3.54	1.33	1.09	2.79
EV/EBIT Ratio	5.95	5.33	5.10	1.59	1.22	3.30
EV/FCF Ratio	18.16	16.28	5.76	5.97	7.24	4.13
Debt / Equity Ratio	0.10	0.10	0.10	0.11	0.13	0.04
Debt / EBITDA Ratio	0.91	0.91	0.96	0.71	0.77	0.36
Debt / FCF Ratio	4.19	4.19	1.56	3.21	5.10	0.53
Asset Turnover	1.76	1.76	1.74	1.85	1.90	1.83
Inventory Turnover	10.75	10.75	10.19	10.95	13.79	14.17
Quick Ratio	1.25	1.25	1.40	1.30	1.29	1.36
Current Ratio	1.60	1.60	1.72	1.66	1.58	1.59
Return on Equity (ROE)	6.21%	6.21%	5.18%	10.69%	10.96%	7.54%
Return on Assets (ROA)	2.03%	2.03%	2.12%	3.62%	4.05%	2.95%
Return on Capital (ROIC)	4.15%	4.15%	4.35%	7.79%	8.91%	6.60%
Return on Capital Employed (ROCE)	6.40%	6.40%	6.40%	11.40%	12.80%	9.50%
Earnings Yield	6.73%	6.97%	5.42%	13.86%	14.34%	7.70%
FCF Yield	2.68%	2.77%	7.32%	4.88%	3.43%	9.12%
Dividend Yield	3.81%	3.95%	3.86%	4.24%	3.58%	2.23%
Payout Ratio	55.84%	55.84%	54.85%	31.97%	15.31%	29.95%
Buyback Yield / Dilution	2.15%	2.15%	-0.16%	0.36%	-2.84%	0.13%
Total Shareholder Return	5.91%	6.10%	3.70%	4.60%	0.73%	2.36%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.